The drugs are Pfizer’s Corvert and vincristine sulfate injection.
Corvert is an anti-arrhythmic heart drug used to treat atrial fibrillation or atrial flutter. Vincristine is a chemotherapy drug, used mostly in childhood cancers.
Both drugs are currently facing shortages, so ProvideGx and Pfizer’s partnership aims to create a long-term supply of the two drugs for hospitals.
ProvideGx said it has a list of more than 50 other drugs currently in shortage it plans to supply in the future.
The financial details of ProvideGx and Pfizer’s partnership weren’t disclosed.
Read the full news release here.
More articles on pharmacy:
21 states reject $18B opioid settlement offer from McKesson, Cardinal, AmerisourceBergen
BCBS responds to physician pushback on mail-order pharmacy plan
The 20 most expensive drugs in the US in 2020
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
